Actively Recruiting
Evaluating the Safety and Tolerability of PCRX-201 Injection in Adults with Painful Knee Osteoarthritis
Led by Pacira Pharmaceuticals, Inc · Updated on 2026-08-25
135
Participants Needed
40
Research Sites
295 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying osteoarthritis of the knee in adults aged 45 to 80 years to evaluate the safety, tolerability, and effects of a single knee injection of PCRX-201 following steroid pretreatment. This Phase 2 trial compares two different doses of PCRX-201 to placebo over one year, focusing on adverse events and treatment impact on knee pain and joint function. Participants will be randomly assigned to receive one of the PCRX-201 doses or placebo after pretreatment with methylprednisolone acetate. The study has two parts, with Part A involving 45 subjects and Part B enrolling 90 subjects, each stratified by disease severity. The injections are given as a single intra-articular dose, and the study drug is manufactured by two different processes. Participants will visit the clinic for pretreatment, drug administration, and multiple follow-ups throughout the study. Visits are weekly or biweekly initially, then monthly until one year, with additional visits up to five years. Researchers will monitor adverse events, measure PCRX-201 levels in blood and skin samples, assess immune response and inflammation markers, and evaluate changes in knee pain and function using standardized scales.
CONDITIONS
Brief Title
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Research Team
L
Lisa Ramsay, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here